BEHRENS M KATHLEEN
SEC CIK 1211701 · EDGAR
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
| 13 | BEHRENS M KATHLEEN | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 20:08 | 2026-06-04 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | A - Grant | — | +16.9K | 214.4K | +9% | — | |
| D | 2026-01-29 | 2026-01-27 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | M - OptEx | $13.71 | +10.5K | 204.0K | +5% | +$144.0K |
| D | 2026-01-29 | 2026-01-27 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | F - Tax | $22.17 | -6,494 | 197.5K | -3% | -$144.0K |
| 2025-06-23 | 2025-06-18 | MDXG | MIMEDX GROUP, INC. | BEHRENS M KATHLEEN | Dir | A - Grant | $6.47 | +28.6K | 212.8K | +16% | +$185.1K | |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | A - Grant | — | +2,383 | 193.5K | +1% | — |
| 2024-09-05 | 2024-09-04 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | G - Gift | $0.00 | -746 | 191.1K | -0.4% | $0 | |
| D | 2024-07-08 | 2024-07-03 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | M - OptEx | $13.90 | +15.0K | 191.8K | +8% | +$208.5K |
| 2024-06-06 | 2024-06-05 | MDXG | MIMEDX GROUP, INC. | BEHRENS M KATHLEEN | Dir | A - Grant | $7.26 | +23.2K | 184.2K | +14% | +$168.4K | |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | A - Grant | $0.00 | +1,846 | 176.8K | +1% | $0 |
| D | 2023-11-06 | 2023-11-03 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | M - OptEx | $29.03 | +15.0K | 175.0K | +9% | +$435.4K |
| 2023-06-15 | 2023-06-13 | MDXG | MIMEDX GROUP, INC. | BEHRENS M KATHLEEN | Dir | A - Grant | $4.95 | +35.4K | 161.0K | +28% | +$175.0K | |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | A - Grant | $0.00 | +1,523 | 160.0K | +1.0% | $0 |
| D | 2022-12-21 | 2022-12-19 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | M - OptEx | $34.92 | +20.0K | 158.5K | +14% | +$698.4K |
| 2022-06-13 | 2022-06-07 | MDXG | MIMEDX GROUP, INC. | BEHRENS M KATHLEEN | Dir | A - Grant | $3.96 | +44.2K | 125.6K | +54% | +$175.0K | |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | A - Grant | $0.00 | +2,953 | 138.5K | +2% | $0 |
| D | 2021-12-16 | 2021-12-15 | SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Dir | M - OptEx | $10.08 | +5,000 | 135.5K | +4% | +$50.4K |
Purchase Sale Sale after option exercise All abbreviations